QDEL(QDEL)
QDEL
Next earnings: Jul 29, 2026 · After close
Signal
Mixed1↑1↓
PRICE
Prev Close
11.39
Open
11.39
Day Range10.31 – 11.54
10.31
11.54
52W Range9.92 – 35.58
9.92
35.58
2% of range
VOLUME & SIZE
Avg Volume
2.2M
FUNDAMENTALS
P/E Ratio
-0.6x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
0.85
Market-like
Performance
1D
-9.39%5D
-3.28%1M
-40.99%3M
-56.23%6M
-51.64%YTD
-63.87%1Y↓
-68.76%Worst: 1Y (-68.76%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
45% gross marginValuation
FAIR
P/E not availableHealth
WEAK
CR 1.4 · FCF negativeNeutral
Key MetricsTTM
Market Cap$703.73M
Revenue TTM$2.66B
Net Income TTM-$1.21B
Free Cash Flow-$75.20M
Gross Margin45.0%
Net Margin-45.6%
Operating Margin-36.9%
Return on Equity-56.3%
Return on Assets-21.5%
Debt / Equity1.55
Current Ratio1.43
EPS TTM$-17.76
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
2 watch4 concern
18/100Liquidity
1.43Watch
Leverage
1.55Watch
Coverage
-5.3xConcern
ROE
-56.3%Concern
ROIC
-19.9%Concern
Cash
$170MConcern
ANALYST COVERAGE15 analysts
HOLD
▲ +18.7%upside to target
L $12.00
Med $12.25consensus
H $12.50Stock Health
Composite Score
0 of 5 signals bullish
3/10
Technicals
●
~RSI RangeRSI 23 — Oversold, watch for bounce
Volume
●
✗Volume FlowDistribution — institutional selling
Fundamentals
●
✗Last EarningsMissed estimates
●
~Analyst ConsensusHold
●
~LiquidityCurrent Ratio 1.43
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 17, 2026
In 93 days
FinancialsFull statements →
Technicals
Technical SetupBEARISH
Technicals →Trend
▼ DowntrendGolden Cross · 50D leads 200D by 7.5%
-56.0% vs SMA 50 · -52.8% vs SMA 200
Momentum
RSI22.7Oversold — potential bounce
MACD-4.43Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$35.58+244.8%
EMA 50
$22.03+113.4%
EMA 200
$21.74+110.7%
Current
$10.32
52W Low
$9.92-3.9%
52-Week RangeNear 52-week low
$9.922th %ile$35.58
Squeeze SetupVolume-based
Distribution PressureDistribution pattern detected. More selling days than accumulation over the past 20 sessions. Not a conducive environment for a squeeze.
20-Day Money Flow
Acc days:2
Dist days:5
Edge:+3 dist
Volume Context
Avg Vol (50D)2.5M
Recent Vol (5D)
2.5M+1%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 5 analysts
Analyst revisions:EPS↑ Revised Up
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $2.7B $2.7B–$2.7B | — | $2.08 | — | ±1% | High5 |
FY2026(current) | $2.7B $2.7B–$2.8B | ▲ +0.9% | $1.83 | ▼ -11.8% | ±9% | Moderate3 |
FY2027 | $2.8B $2.8B–$2.9B | ▲ +3.4% | $2.55 | ▲ +38.9% | ±7% | Moderate4 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryQDEL
Last 8Q
+19.7%avg beat
Beat 6 of 8 quartersMissed 2↑ Estimates rising+67%
Q3'24
+174%
Q4'24
+15%
Q1'25
+28%
Q2'25
-79%
Q3'25
+57%
Q4'25
+7%
Q1'26
-111%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced heightAnalyst Activity
All ratings →Analysts turning cautious
30d▲ 0▼ 1
90d▲ 0▼ 1
JefferiesHold
May 7
DOWNGRADE
CitigroupBuy → Neutral
Oct 7
DOWNGRADE
CitigroupBuy
Dec 11
UPGRADE
UBSNeutral
Sep 19
UPGRADE
Craig-HallumBuy
Sep 5
UPGRADE
Raymond JamesStrong Buy → Outperform
Feb 14
DOWNGRADE
William BlairMarket Perform
Feb 14
DOWNGRADE
CitigroupBuy
Dec 12
UPGRADE
Insider Activity
SEC Filings →5 Buys/1 SellNet Buying
Strobeck MatthewDir
$240K
Feb 13
BUY
Busky Joseph M.CFO
$80K
Feb 13
BUY
Blaser Brian J.President and …
$249K
Feb 13
BUY
Rhoads Ann DDir
$21K
Dec 10
BUY
Wilkins Joseph D Jr.Dir
$10K
Nov 26
BUY
Widder Kenneth JDir
$112K
Nov 25
SELL
Financials
INSTITUTIONAL OWNERSHIP
1
BlackRock, Inc.
10.4M▲2
FMR LLC
6.6M▲3
T. Rowe Price Investment Management, Inc.
5.6M▼4
Newtyn Management, LLC
4.6M▲5
Rubric Capital Management LP
3.3M▼6
Invesco Ltd.
3.1M▼7
DIMENSIONAL FUND ADVISORS LP
3.0M▲8
AMERICAN CENTURY COMPANIES INC
2.9M▲News & Activity
QDEL News
About
QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.
Sector
Industry
Surgical and Medical Instrument Manufacturing
CEO
Douglas C. Bryant
Website
Brian J. BlaserPresident, Chief Executive Officer & Director
Erich WolffExecutive Vice President of Strategy & Corporate Development
Jonathan SiegristExecutive Vice President of Research & Development and Chief Technology Officer
Peers— Health Care(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
QDEL◀ | $10.32 | -9.39% | $704M | — | -189.4% | -4145.5% | 1500 |
| $66.13 | -5.07% | $13.0B | — | +12626.1% | -14525.8% | 1500 | |
| $94.92 | -3.79% | $12.6B | — | +3288.2% | -4239.0% | 1500 | |
| $523.69 | -3.00% | $12.1B | — | +43205.3% | -3008.0% | 1500 | |
| $227.72 | -1.30% | $11.7B | — | +6554.5% | -2868.8% | 1500 | |
| $57.90 | -0.86% | $11.2B | 50.3 | +1459.3% | 147.7% | 1500 | |
| $76.67 | -3.79% | $10.8B | — | +2325815.3% | -19.7% | 1500 | |
| Sector avg | — | -3.89% | — | 50.3 | +341822.8% | -4094.1% | 1500 |